Richard Grant to Cost-Benefit Analysis
This is a "connection" page, showing publications Richard Grant has written about Cost-Benefit Analysis.
Connection Strength
0.237
-
Patients who self-monitor blood glucose and their unused testing results. Am J Manag Care. 2015 Feb 01; 21(2):e119-29.
Score: 0.117
-
Intensification of diabetes medication and risk for 30-day readmission. Diabet Med. 2013 Feb; 30(2):e56-62.
Score: 0.102
-
Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis. Clin Ther. 2008 Feb; 30(2):358-71.
Score: 0.018